zirconium has been researched along with globotriaosylceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, JH; Hong, SE; Hwang, WM; Kang, J; Lee, DC; Lee, HY; Lee, SK; Park, CG; Park, HW; Park, MH; Park, Y; Yoon, KR; Yoon, SH; Yu, SL; Yun, SR | 1 |
1 other study(ies) available for zirconium and globotriaosylceramide
| Article | Year |
|---|---|
Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease.
Topics: Animals; Autophagy; Disease Models, Animal; Fabry Disease; Kidney; Male; Mice; Nanoparticles; Trihexosylceramides; Zirconium | 2022 |